Bupropion: ved steady- state blev bupropion og dens aktive metabolit hydroxybupropions AUC og Cmax nedsat med omkring 50% hos raske frivillige ved samtidig administration med lopinavir/ ritonavir kapsler 400/ 100 mg to gange daglig.
Bupropion: in healthy volunteers, the AUC and Cmax of bupropion and of its active metabolite, hydroxybupropion, were decreased by about 50% when co-administered with lopinavir/ ritonavir capsules 400/ 100 mg twice daily at steady-state.